It is a healthcare private limited company based in Thane, Maharashtra, India, established in 2010.
2010 | Thane, Maharashtra, India | Struck OffNano Diagnostics Private Limited, a struck off private limited company, was established on 13 December 2010 in Thane, Maharashtra, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U85191MH2010PTC210906. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sagar Chandramohan Galwankar (Managing Director), Madhu Sudan Padhy (Director). Past directors included Sagar Chandramohan Galwankar, Subhra Mohapatra, Rita Ramesh Paranjape. Its latest AGM occurred on 27 September 2019, with the balance sheet filed on 31 March 2019. It is based at Dr S.K. Galwankar Hospital, Bhasker Ali Vasai (West), Thane, Maharashtra, 401201.
U85191MH2010PTC210906
210906
13 December 2010
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Nano Diagnostics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sagar Chandramohan Galwankar | Managing Director | 01 Jul 2012 | Current |
| Madhu Sudan Padhy | Director | 12 Jul 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 12 Jul 2012 | Past |
| Pramod Abcsdd | Director | 20 Jul 2019 | Past |
| Pramod Abcsdd | Director | 10 Jul 2019 | Past |
| Pramod Abcsdd | Director | 08 Jul 2019 | Past |
| Pramod Abcsdd | Additional Director | 20 Sep 2012 | Past |
| Pramod Abcsdd | Director | 20 Jul 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nano Diagnostics Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 39.85% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.48%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Nano Diagnostics had a promoter holding of 1.00% and a public holding of 99.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Nano Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nano Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nano Diagnostics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nano Diagnostics Private Limited last Annual general meeting of members was held on 27 Sep 2019 as per latest MCA records. was completed.
Nano Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Mumbai. was recorded as a recent event.
Progress on Madhu Sudan Padhy was appointed as a Director was appointed as a Director on 12 Jul 2012 & has been associated with this company since 13 years 5 months . was documented.
Sagar Chandramohan Galwankar was appointed as a Managing Director was appointed as a Managing Director on 01 Jul 2012 & has been associated with this company since 13 years 5 months . was recorded as a recent event.
Nano Diagnostics Private Limited was registered on 13 Dec 2010 with Roc Mumbai & aged 15 years 11 days as per MCA records. was recorded as a recent event.
The CIN of Nano Diagnostics Private Limited is U85191MH2010PTC210906.
Nano Diagnostics Private Limited is headquartered at Dr S.K. Galwankar Hospital, Bhasker Ali Vasai (West), Thane, Maharashtra, 401201.
Nano Diagnostics Private Limited was incorporated on 13 December 2010.
The current directors of Nano Diagnostics Private Limited are
The primary industry of Nano Diagnostics Private Limited is Hospital And Medical Care.
Nano Diagnostics Private Limited is unlisted.
The authorized capital of Nano Diagnostics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Nano Diagnostics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX